To investigate the efficacy of low-density lipoprotein (LDL) transport simulation in reconstructed arteries derived from computed tomography coronary angiography (CTCA) to predict coronary segments that are prone to progress.
Introduction
Cumulative evidence has shown that the local haemodynamic forces regulate atherosclerotic evolution and the formation of high-risk vulnerable plaques. Recently, in vivo intravascular imaging-based studies have shown that segments that are exposed to a low endothelial shear stress (ESS) environment exhibit more often disease progression and that low ESS is an independent predictor of future revascularizations. 1, 2 Nevertheless, the association between the changes in the plaque burden and ESS is weak in clinical studies, while reports that performed a detailed point-by-point analysis have shown no association between baseline ESS and changes in the vessel wall thickness. The above evidence indicates that although ESS affects atherosclerotic evolution, it may not be the most important haemodynamic metric that regulates this process. Low-density lipoprotein (LDL) transport is the first pathophysiological mechanism regulating atherosclerotic lesions formation. Although there are other metabolic pathways that are involved in atherosclerotic process, this is the most important at the early stage of plaque development. Several methodologies have been recently introduced to simulate this process; however, their efficacy in predicting atherosclerotic disease progression is yet unclear. 3 -6 In this study, we process for the first time the use of serial computed tomography coronary angiography (CTCA) to assess the efficacy of an LDL transport simulation methodology in predicting segments that will exhibit atherosclerotic disease progression at 3-year follow-up.
Methods

Studied population
We retrospectively analysed data from the patients enrolled in the PROSPECT-MSCT study. The design and inclusion criteria of the study have been previously described. 7 In brief, 32 patients who presented with an acute coronary syndrome (ACS) were prospectively enrolled in the PROSPECT study at the Erasmus Medical Center. 8 CTCA imaging was performed at baseline [after percutaneous coronary intervention (PCI) of the culprit lesion(s) responsible for the ACS] and at 3-year follow-up according to the research protocol. Patients with an irregular cardiac rhythm, a heart rate .70 bpm, impaired renal function, or prior bypass surgery were excluded from the study. The study complied with the Declaration of Helsinki, and was approved by the review board of Erasmus Medical Center; all patients provided written informed consent before being recruited in the study. Blood samples were obtained from all the studied patients to assess their lipid profile.
CTCA image acquisition
CTCA was performed at baseline with a 64-slice scanner (Sensation 64, Siemens Medical Solutions, Forchheim, Germany) and at follow-up with a 64-slice dual-source CT scanner (Somatom Definition, Siemens Medical Solutions, Forchheim, Germany). The CTCA scan parameters at baseline were 330 ms gantry rotation time, 32 × 2 slices per rotation, 0.6 mm detector collimation, and spiral scan mode with a table feed of 3.8 mm per rotation, while the tube voltage was 120 kV, and the tube current 900 effective mAs. A bolus of 100 mL contrast (400 mg/ mL; Iomeron, Bracco, Milan, Italy) was intravenously injected at a rate of 5 mL/s. A bolus tracking technique was implemented to detect the presence of contrast in the coronaries and initiate CTCA imaging. ECGtriggered X-ray tube modulation was not applied. At follow-up, the CTCA scan parameters were gantry rotation time 330 ms, 32 × 2 × 0.6 mm collimation with z-flying focal spot for both detectors, tube voltage of 120 kV, and tube current of 320 -412 mAs per rotation. Depending on the expected scan time, 60 -100 mL iodinated contrast material (370 mg/mL; Ultravist, Schering, Berlin, Germany) was injected intravenously at 5.5 mL/s. A bolus tracking technique was used to detect the arrival of contrast in the coronary arteries and initiate image acquisition, and a spiral scan protocol with prospective ECG-triggered X-ray tube modulation and variable table feed depending on the heart rate was applied for the follow-up examination.
The CTCA images acquired at baseline and follow-up were reconstructed with a slice thickness of 0.75 and 0.4 mm increments using a retrospective at baseline, and a prospective at follow-up scan ECGgating algorithm to obtain optimal, motion-free image quality. Optimal data sets with the best image quality were reconstructed mainly in the mid-to end-diastolic phase, using a medium-smooth convolution kernel. The mean effective radiation dose was 14.0 + 0.8 mSv at baseline and 10.0 + 3.2 mSv at follow-up.
CTCA data processing
The acquired CTCA data were transferred to a workstation (QAngioCT Research Edition version 2.0.3, Medis Medical Imaging Systems, Leiden, The Netherlands) and analysed offline by an experienced operator with known reliability and reproducibility. 7 Image analysis was performed blinded to patients' characteristics and the sequence of imaging.
Only the three major epicardial arteries were included in this analysis. The operator reviewed the data sets and used anatomical landmarks (i.e. the ostium of a coronary artery or side branches) to identify corresponding segments between the baseline and follow-up examination. Short segments (length ,15 mm), segments located distally to a stented artery and these with poor image quality (assessed visually by an expert observer) due to stack or movement artefacts, or extreme calcification were excluded from the analysis. Large side branches (lumen diameter .1.5 mm) originating from epicardial coronary segments were included and were segmented by the operator who annotated only the lumen borders for a length of 20 mm. Lumen and outer vessel wall border detection was performed using a stepwise approach. First, a centreline originating from the ostium of the coronary artery was automatically extracted. Then, straightened multiplanar reformatted images were generated and the lumen and outer vessel wall borders were automatically detected in four different longitudinal vessel views by the software ( Figure 1A ). On the basis of these longitudinal contours, cross-sectional images at 0.5 mm intervals were defined. The lumen and outer vessel wall borders were automatically extracted in the cross-sectional images and assessed by the operator who made adjustments whenever it was necessary ( Figure 1B and D) . Gradient magnitude images generated from the CTCA images were used to facilitate the accurate detection of the outer vessel wall border as they allowed assessment of the degree of CTCA image intensity change ( Figure 1) .
The plaque area was further processed by an automated wellvalidated plaque characterization methodology, which permitted identification of four tissue types (necrotic core, fibrofatty, fibrous, and calcific tissue, Figure 1G ). The proposed approach relied on the use of Hounsfield unit thresholds that were adapted based on the lumen attenuation values to characterize the composition of the plaque. 9 Reconstruction of coronary anatomy A three-dimensional (3D) surface mesh representation of the lumen and outer vessel wall borders was constructed. Initially, the planar borders of the lumen and outer vessel wall, detected in the straightened multi-planar reformatted images, were transformed back into the original reformat orientations within the CTCA volume and used to calculate an implicit volume function. If a coronary bifurcation was present, the implicit functions from the borders of the main and the daughter branches were combined to construct a final implicit function that included all the coronary segments. Finally, a smooth surface mesh was generated by fitting a subdivision surface to the zero value of the final implicit volume function ( Figure 2 ).
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Blood flow and LDL transport simulation
In the reconstructed geometries, a finite volume mesh was generated. We model blood flow by solving Navier -Stokes equations and by A. Sakellarios et al.
applying the appropriate boundary conditions, which are the blood velocity at the inlet of the arterial segment, a zero pressure boundary condition at the outlet, and a transmural flux across the endothelial membrane. We also define a plasma flow in the arterial wall by assuming that the arterial wall is a homogeneous porous media, and the Darcy's law is developed for the estimation of the flow inside the arterial wall.
To measure LDL concentration, we solve the convection -diffusion equation in the arterial lumen and wall. We apply an inlet patientspecific LDL concentration, and assume a solute flux across the endothelial membrane, which defines the degree of LDL penetration across the endothelial membrane. To estimate the transmural and solute flux across the endothelial membrane, we use the KedemKatschalsky equations 11 assuming that the endothelial membrane reacts as a biological semi-permeable membrane. The methodology was previously presented in detail and was implemented using several flow conditions. 4 The proposed approach assumes that LDL particles are transferred due to convection and diffusion from the luminal to the arterial wall domain, that the LDL particle's size does not affect the blood flow, and that the endothelial permeability is ESS dependent.
The blood was assumed to be homogeneous, Newtonian fluid with dynamic viscosity of 0.0035 Pa . s, and density of 1050 kg/m 3 . Blood flow was considered to be laminar and incompressible with a steady flow profile. It was assumed that the flow profile was fully developed within the first 3 mm of the reconstructed model. The arterial wall was considered to be rigid, and no-slip conditions were applied at the baseline luminal surface. Murray's law was used to estimate flow in the daughter branches of bifurcations. Two angiographic images acquired during PCI were used to define patient-specific coronary blood flow velocity, which was applied as boundary condition at the inlet of the models to calculate the ESS at the baseline luminal surfaces.
Data analysis
The baseline and follow-up coronary models were divided in consecutive 3 mm sub-segments that-as has been shown in the PREDICTION study-appear able to permit reliable assessment of the effect of ESS on plaque characteristics. 1 The most proximal and distal 3 mm subsegments were excluded from the analysis. For the rest, we estimated in each segment the mean lumen area, the mean outer vessel wall area, the mean plaque area, the mean plaque burden (calculated as: 100 × mean plaque area/mean outer vessel wall area), the mean plaque composition (necrotic core, fibrofatty, fibrous, and calcific tissue area), and the percentage of each plaque component. The vascular remodelling pattern was assessed in the baseline models according to the consensus document proposed for the analysis of intravascular ultrasound data, and we determined the local predominant ESS (defined as the minimum averaged ESS in an arc of 908) and the LDL concentration value (defined as the maximum averaged LDL concentration in an arc of 908).
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Statistics
The Kolmogorov-Smirnov test was used to examine the distribution of the numerical variables; a non-normal distribution was found and thus the results are presented as median with 25th and 75th centiles. Categorical variables are presented as absolute values and percentages. The predominant ESS values were divided in tertiles to classify the 3 mm sub-segments into low ESS (,1.14 Pa), moderate ESS (≥1.14 and ,1.77 Pa) and high ESS (≥1.77 Pa) groups. The median LDL concentration value was used to divide the LDL values into two categories (high and low). To compare the baseline characteristics between groups, the x 2 test was used for categorical variables, the MannWhitney U test was used to compare continuous variables in two groups, and the Kruskal-Wallis H test in ≥3 groups. Linear regression analysis was used to investigate the association between ESS, LDL accumulation, baseline plaque characteristics, and changes in the lumen dimensions (Dlumen: mean lumen area at follow-up 2 mean lumen area at baseline), the plaque (Dplaque: mean plaque area at follow-up 2 mean plaque area at baseline), the plaque burden (Dplaque burden: mean plaque burden at follow-up 2 mean plaque burden at baseline), and the necrotic core component (Dnecrotic core: mean necrotic core at follow-up 2 mean necrotic core at baseline). The variables associated (P , 0.1) with these changes were entered into a multivariate linear regression model to identify independent predictors. In case of co-linearity (r . 0.8 and P , 0.05), the variables that had a higher level of significance were included in the multivariate model. 13 To control for patient effect, a mixed model with random intercept and slope was used.
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Binary logistic regression analysis was performed to identify the CTCA-derived variables associated with a significant atherosclerotic disease progression in the 3 mm sub-segments defined as an increase in plaque burden at follow-up that was higher than 2SD (.14.7%) of the inter-observed variability of the expert who performed the analysis. To control for patient effect, a mixed model was used. For the continuous variables with P , 0.1, receiver operating characteristic (ROC) curve analysis was performed and used to define the optimal cut-off value that predicted plaque progression. The binary variables defined by these cut-off values were entered into a multivariate model to identify independent predictors of disease progression. A risk score was then assigned to each independent predictor based on the odds ratio (OR), and a total risk score was estimated. The sensitivity, specificity, positive and negative predictive values, the positive and negative likelihood ratios, and the accuracy of the score developed to identify 3 mm sub-segments that exhibited disease progression at follow-up were assessed using ROC curve analysis. Data analysis was performed using the SAS version 9.3 (SAS Institute). A P-value of , 0.05 was considered statistically significant.
Results
Thirty-two patients who had CTCA at baseline and after 39 (37 -40) months follow-up were included in the current analysis. The baseline characteristics of the studied patients are shown in the Supplementary data online, Table S1. All the patients received dual antiplatelet treatment and routine standard of care therapy including statins at discharge. From this data set, 58 coronary arteries with a median length of 41.3 (25.4 -55.4) mm were reconstructed. 14 After excluding the proximal and distal 3 mm segment, 735 segments were included in the final analysis. As it is shown in the Supplementary data online, Table S2 , there was disease progression at follow-up as the plaque area was increased at this time point.
The median local ESS value at baseline was 1.45 (0.99-2.02) Pa, and the median normalized LDL concentration value was 0.10 (0.09-0.11). The normalization was made using the inlet LDL concentration. There were no differences in the composition of the plaque in the three ESS subgroups (Supplementary data online, Table S3 ). On the other hand, segments with high LDL concentration had an increased necrotic core component and a decreased fibrotic and calcific tissue component (Supplementary data Online, Table S4 ). Low ESS and increased LDL accumulation were seen more often in segments with compensatory or positive remodelling comparing with those that exhibit restrictive remodelling (Supplementary data Online, Figure S1 ). A case example of ESS distribution and LDL accumulation into the arterial wall is shown in Figure 3 .
Effect of the LDL accumulation and plaque characteristics on the changes in the luminal and plaque dimensions
The univariate analyses of the CTCA-derived variables associated with a reduction in luminal dimensions, an increase in plaque area and burden, and an increase in the necrotic core component have already been presented. 14 In multivariate analysis and after excluding co-linear variables, high LDL concentration, and not the ESS, was independently correlated with a lumen reduction and plaque burden increase ( Table 1) . Neither high LDL concentration nor low ESS was independent predictors of plaque area and necrotic core increase ( Table 1) .
Prognostic value of CTCA-derived variables in detecting segments with a significant plaque burden increase at follow-up
Binary logistic regression analysis was performed to identify predictors of significant disease progression ( Table 2) . Although low ESS and high LDL accumulation appeared as predictors of disease progression in the multivariate analysis, only the high LDL concentration appeared to independently predict atherosclerotic disease progression. When the LDL concentration was excluded from the analysis, the ESS was an independent predictor of the plaque progression. The accuracy, sensitivity, specificity, and positive and negative predictive values of the model that included the LDL accumulation were higher than the corresponding values of the model created when the LDL accumulation was excluded from the analysis 
Discussion
In the present analysis, we investigated, for the first time, the value of LDL transport modelling in predicting segments that are likely to exhibit disease progression on CTCA at 3-year follow-up. We found that (i) an increased LDL accumulation is seen in segments with a higher necrotic core component and positive/compensatory remodelling, (ii) an increased LDL accumulation and not low ESS is independently associated with luminal reduction and plaque burden increase at follow-up, and (iii) LDL accumulation and not low ESS is an independent predictor of significant plaque progression at 3-year follow-up. In contrast to the ESS simulation, the LDL transport simulation is the first that takes into account local (blood flow patterns) and systemic factors (LDL concentration) to predict plaque progression and thus it is likely to be more reliable. Statistically, we found that LDL accumulation is a more significant predictor than ESS. Several invasive imaging-based studies have examined the role of the local haemodynamic forces on atherosclerotic lesion formation and demonstrated that low ESS promotes plaque growth and the formation of high-risk vulnerable lesions. These findings substantiate evidence from experimental studies, which shows that low ESS promotes endothelial permeability and endothelial dysfunction and activates the production of growth factors, inflammatory mediators, neo-vessel formation, and platelet aggregation that result in the formation of vulnerable high-risk lesions. 15 -20 Although ESS regulates through several mechano-transduction pathways the biology of the vessel, its predictive value in detecting lesions that are likely to progress is low. This can be attributed to the assumptions that are made during modelling (i.e. the side branches are not included in most of the models) 21 and blood flow simulation (steady flow simulation, approximation in the boundary conditions), as well as to the limited ability to identify exact correspondence between baseline and follow-up models. In the present study, we examined, for the first time, the effect of LDL accumulation on luminal dimensions, plaque composition, and burden in non-stenotic arterial segments. We found a strong association between the computed LDL deposition into the vessel wall and the changes in luminal dimensions, plaque burden, and necrotic core component. In multivariate analysis, LDL deposition competed with the ESS and appeared as a stronger and independent predictor of luminal reduction and plaque growth. The superiority of the LDL transport modelling over ESS can be attributed to several reasons. First of all, this study included segments with no significant coronary artery disease, where lipid accumulation appears as the most important mechanism that regulates plaque evolution. 22, 23 In addition, the model used to assess LDL accumulation assumes that endothelial permeability is ESS dependent and thus although there was no co-linearity between LDL concentration and ESS, there is an association between these two variables. Finally, clinical evidence demonstrates that plaque development may also occur at regions where the ESS is high.
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Limitations A significant limitation of the present analysis is the small number of patients and studied segments that do not allow us to draw safe conclusions about the superiority of LDL transport simulation in predicting segments that will exhibit disease progression at follow-up. Therefore, further analyses in larger data sets are required in order to assess more accurately the value of this modelling in predicting atherosclerotic disease progression and examine its potential in detecting lesions prone to progress and cause events. CTCA imaging may enable reliable non-invasive assessment of the luminal dimensions and plaque burden, but it has limited accuracy in detecting plaque composition. 25 -27 This may also justify the fact that LDL accumulation was not an independent predictor of the changes in the composition of the plaque. Another limitation of the present study is that the lipid profile and LDL concentration was measured at baseline on index admission. ACS and treatment with statins can affect the lipid profile. These effects have not been taken into account and are likely to affect the accuracy of the prediction made based on LDL simulation modelling approach.
Finally, the proposed methodology is computationally expensive. In particular, blood flow simulation and estimation of the ESS requires 10 min in a computer with a quad core processor, while LDL transport modelling requires about 1 h. However, parallel processing can reduce this time considerably. Therefore further research and prospective validation of this simulation in other data sets are needed before advocating its broad use in large clinical studies.
Conclusions
Our analysis is the first that demonstrated the potential role of LDL transport modelling in detecting lesions that are likely to progress. We found that LDL accumulation is a stronger predictor of luminal reduction and plaque progression than the ESS. Future studies using The multivariate analysis was performed with categorical variables. For each continuous variable with a P-value of ,0.1 in the univariate analysis, an ROC curve analysis was performed to define the optimal cut-off value that predicted plaque burden increase, and this was used to transform the continuous variables to categorical that were then entered into the multivariate model. The best cut-off value for the plaque area and plaque burden that predicted significant plaque progression was 7.97 mm 2 and 46.8%, respectively.
these complex simulation techniques in larger patient populations are required to assess their efficacy in identifying future culprit lesions. 0.751) in identifying segments that will exhibit disease progression at follow-up. *P-value concerns the P against the null hypothesis that the true area equals to 0.5.
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